Key result
Brazilian ASTA-symptom scale demonstrates strong validity and reliable consistency for tachyarrhythmia symptom assessment.
Why the study?
In Brazil, no scale was available to evaluate patient-reported symptoms across different types of arrhythmias to inform clinical decisions and treatment.
Is the Brazilian version of the ASTA-symptom scale a valid and reliable tool to assess symptom burden in patients with tachyarrhythmia?
Cross-Sectional (n=140)
Yes
Is the Brazilian version of the ASTA-symptom scale a valid and reliable tool to assess symptom burden in patients with tachyarrhythmia?
The Brazilian version of the ASTA-symptom scale is a valid and reliable patient-reported outcome measure for assessing symptom burden in patients with tachyarrhythmias.
Answers are grounded in this paper and cite their sources.
Supports Brazilian ASTA-symptom scale for tachyarrhythmia assessment; extends validation but leaves open for routine clinical use.
INTRODUCTION: The wide variety of symptoms in patients with cardiac arrhythmias can affect daily living activities. The evaluation of symptoms with patient-reported outcome measures (PROMs), with validated instruments, can provide information that contributes to clinical decisions and treatment. In Brazil, however, there is no available scale that evaluates symptoms in different types of arrhythmias. PURPOSE: This study aimed to translate the Arrhythmia-Specific Questionnaire in Tachycardia and Arrhythmia symptom scale (ASTA-symptom scale) and then validate the questionnaire in terms of Brazilian culture. METHOD: The methodological process of cultural adaptation used was based on international literature guidelines consisting of forward translation, synthesis, back translation, review by an expert committee, and pretest. Psychometric analyses were conducted with 140 patients. These included measuring internal consistency (Cronbach's alpha), construct validity with item-total correlations, and convergent construct validity with correlations with the quality of life questionnaire for patients with atrial fibrillation-version 2 (QVFA-v2). Usability and understandability were evaluated through the usability evaluation of instruments. RESULTS: (0.79). Construct validity was demonstrated by item-total correlations for the nine items, all except one reached the level of >0.30 (0.24). Convergent validity showed a high correlation with QVFA-v2 (0.89). As for the evaluation of usability and understanding, after two small suggested changes, no additional alterations were necessary. CONCLUSION: The psychometric properties of the Brazilian version of ASTA-symptom scale evaluated in this study were satisfactory, and the scale was proved to be a valid and reliable tool to assess the symptom burden in patients with different forms of tachyarrhythmia. The ASTA-Br-symptom scale questionnaire can be an important addition to PROMs for patients with arrhythmias and could help healthcare professionals in decision-making.
No takes yet. Share an insight, caveat, or question.
Cannavan et al. (2020) conducted a cross-sectional in Cardiac arrhythmias (tachyarrhythmia) (n=140). ASTA-Br-symptom scale was evaluated on Internal consistency (Cronbach's alpha). The Brazilian version of the ASTA-symptom scale demonstrated satisfactory internal consistency (Cronbach's alpha = 0.79) and strong convergent validity (r = 0.89, p < 0.0001) for assessing symptom burden in patients with tachyarrhythmia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: